An Electronic Health Record based Dashboard-driven Intervention to Improve Identification and Management of Preventive Care for Cardiovascular Disease
基于电子健康记录的仪表板驱动的干预措施,以改善心血管疾病预防性护理的识别和管理
基本信息
- 批准号:10238854
- 负责人:
- 金额:$ 25.91万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-08-15 至 2022-07-31
- 项目状态:已结题
- 来源:
- 关键词:AdoptionAdultAffectAfrican AmericanAgeAreaAspirinBlood Pressure MonitorsCardiovascular DiseasesCaringChronicClinicClinicalCluster randomized trialCodeCommunicationCounselingDevelopmentDiabetes MellitusDietEffectivenessElectronic Health RecordElementsEngineeringEthnic OriginGeographyGoalsGuidelinesHealth BenefitHealth Services AccessibilityHealth educationHealthcare SystemsHyperlipidemiaHypertensionIncidenceInterventionLearningLife StyleNamesPatient CarePatient EducationPatientsPersonsPharmaceutical PreparationsPhasePhysical activityPhysiciansPreventionPreventivePreventive carePrimary Care PhysicianPrimary Health CareProcessQualitative MethodsRaceRandomized Controlled TrialsRecommendationResearchRiskRisk EstimateRisk FactorsRunningSiteSmokingSystemTechnologyTestingTimeTranslatingTreatment EfficacyUnited StatesVariantVisitWorkage groupbaseburden of illnessburnoutcardiovascular disorder riskcardiovascular risk factorcare providerscostdashboarddesigndigitalefficacy evaluationethnic minority populationfollow-upgroup interventionhealth disparityhealth literacyhealth managementhealth seeking behaviorimprovedliteracymembermortalitynon-complianceoperationpatient engagementpoint of carepopulation healthpreventprimary care settingprovider factorsracial minorityrandomized trialscreeningshared decision makingsmoking cessationsystems researchtoolunhealthy lifestyle
项目摘要
Cardiovascular disease (CVD) is the leading cause of mortality both in the United States and in the world, and
is one of the most costly chronic conditions. The incidence of CVD triples at age 40-50 compared to younger
age, and increases 50% or more at each decade of age after that, is also strongly associated to race and
ethnicity. Though CVD related preventive cares have been recommended by USPSTF guideline, only less than
40% at risk patients complete one of those preventive cares timely. The objective of the project is to develop,
implement, and evaluate an electronic health record (EHR)-based preventive care dashboard management
tool and team-based intervention to improve compliance of CVD related preventive care for primary care
patients 50 years and older. The proposed dashboard is seamlessly integrated within the electronic health
record (EHR) to: (a) identify adults with CVD risk; (b) suggest personalized CVD related preventive
components and associated recommendations of action (e.g. screening test order, medication order, etc.) at
point-of-care visit with primary care providers; and (c) engage population health management teams between
visits. The development and pilot test will take place during R61 phase. In the R33 phase, we rigorously test
the impact of the tool using a cluster randomized controlled trial with ~200 primary care physicians and assess
intervention impact on completion of 4 key preventive care elements for patients at risk for CVD: (1) diabetes
screening, (2) blood pressure monitoring; (3) lifestyle (smoking cessation, diet and physical activities); (4)
appropriate aspirin and statin use. The intervention, referred to as CVD Preventive Care Dashboard
Management (CVD-PCDM) tool, provides patient-specific and clinician-specific CVD preventive care
recommendations and risk estimate in low-literacy format to the primary care provider (PCP) and patients at
each primary care encounter to facilitate shared decision making and patient education. This CVD-PCDM will
be co-designed with clinicians using a successful digital solution development and test cycle which has been
tested in other similar dashboard systems current running at Sutter, and implemented in primary care clinics.
Scalability of the CVD-PCDM will be first tested within Sutter in two geographically and racially distinct
operation units. Meanwhile, we will also identify one health care system from Health Care System Research
Network (HCSRN) to duplicate the intervention and assess the effect. HCSRN consists of large health care
systems in the US, and has actively promoted collaborative research. If the CVD-PCDM is effective at Sutter,
the codes and development package will be shared with the second site. We will design a digital solution
scalable pipeline that can be rapidly and consistently translates this guideline-based preventive care into
delivery of personalized and coordinated CVD care within primary care settings.
心血管疾病(CVD)是美国和世界上死亡的主要原因,以及
是最昂贵的慢性病之一。与年轻人相比
年龄,在此之后的每个十年中增加了50%或更多,也与种族和
种族。尽管USPSTF指南建议使用与CVD相关的预防性护理,但仅小于
有40%的风险患者及时完成其中一种预防性关心。该项目的目的是开发,
实施并评估基于电子健康记录(EHR)的预防保健仪表板管理
基于工具和团队的干预措施,以提高CVD相关的预防性护理的基础护理
患者50岁以上。提出的仪表板无缝集成在电子健康中
记录(EHR)至:(a)确定具有CVD风险的成年人; (b)建议个性化CVD相关的预防性
组件和相关的行动建议(例如筛查测试顺序,药物订单等)
与初级保健提供者的临时访问; (c)与人口健康管理团队互动
访问。开发和试点测试将在R61阶段进行。在R33阶段,我们严格测试
使用〜200个初级保健医生的簇随机对照试验的工具的影响,并评估
干预对有CVD风险的患者的4个关键预防护理元件的完成影响:(1)糖尿病
筛查,(2)血压监测; (3)生活方式(戒烟,饮食和体育活动); (4)
适当的阿司匹林和他汀类药物的使用。干预措施,称为CVD预防护理仪表板
管理(CVD-PCDM)工具,提供特定于患者和临床医生特定的CVD预防保健
针对初级保健提供者(PCP)和患者的建议和风险估算
每次初级保健遇到,以促进共同的决策和患者教育。这个CVD-PCDM将
使用成功的数字解决方案开发和测试周期与临床医生共同设计
在Sutter运行的其他类似仪表板系统中进行了测试,并在初级保健诊所实施。
CVD-PCDM的可伸缩性将首先在Sutter中进行两个地理和种族不同
操作单位。同时,我们还将从医疗系统研究中确定一个医疗保健系统
网络(HCSRN)复制干预措施并评估效果。 HCSRN由大型医疗保健组成
美国的系统,并积极促进了协作研究。如果CVD-PCDM在Sutter上有效
代码和开发包将与第二个站点共享。我们将设计一个数字解决方案
可扩展的管道可以迅速且一致地将基于指南的预防保健转化为
在初级保健环境中提供个性化和协调的CVD护理。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
James Brian Jones其他文献
James Brian Jones的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('James Brian Jones', 18)}}的其他基金
Inpatient-Outpatient Transitions: Reducing the Rate of Readmission
住院病人到门诊病人的转变:降低再入院率
- 批准号:
7363462 - 财政年份:2007
- 资助金额:
$ 25.91万 - 项目类别:
相似国自然基金
成人免疫性血小板减少症(ITP)中血小板因子4(PF4)通过调节CD4+T淋巴细胞糖酵解水平影响Th17/Treg平衡的病理机制研究
- 批准号:82370133
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
儿童期受虐经历影响成年人群幸福感:行为、神经机制与干预研究
- 批准号:32371121
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
依恋相关情景模拟对成人依恋安全感的影响及机制
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
依恋相关情景模拟对成人依恋安全感的影响及机制
- 批准号:32200888
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
生活方式及遗传背景对成人不同生命阶段寿命及死亡的影响及机制的队列研究
- 批准号:82173590
- 批准年份:2021
- 资助金额:56.00 万元
- 项目类别:面上项目
相似海外基金
Efficacy and implementation of exercise-based smoking cessation treatment for adults with high anxiety sensitivity
以运动为基础的戒烟治疗对高焦虑敏感性成人的疗效和实施
- 批准号:
10660767 - 财政年份:2023
- 资助金额:
$ 25.91万 - 项目类别:
Team Support to Improve Glycemic Control Using CGM in Diverse Populations (TEAM CGM)
团队支持在不同人群中使用 CGM 改善血糖控制 (TEAM CGM)
- 批准号:
10659721 - 财政年份:2023
- 资助金额:
$ 25.91万 - 项目类别:
Screening strategies for sexually transmitted infections in a high HIV incidence setting in South Africa
南非艾滋病毒高发地区的性传播感染筛查策略
- 批准号:
10761853 - 财政年份:2023
- 资助金额:
$ 25.91万 - 项目类别:
MRWeight: Medical Residents Learning Weight Management Counseling Skills -- A Multi-Modal, Technology-Assisted, Spaced Education Program
MRWeight:住院医生学习体重管理咨询技能——多模式、技术辅助、间隔教育计划
- 批准号:
10561356 - 财政年份:2023
- 资助金额:
$ 25.91万 - 项目类别: